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Human blood plasma factors 
affect the adhesion kinetics 
of Staphylococcus aureus to central 
venous catheters
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Johannes Mischo2, Ben Wieland1, Carlos Metz4, Becker Sören L.1, Matthias Hannig3, 
Karin Jacobs2,5 & Markus Bischoff1*
Staphylococcus aureus is a common cause of catheter-related blood stream infections (CRBSI). The 
bacterium has the ability to form multilayered biofilms on implanted material, which usually requires 
the removal of the implanted medical device. A first major step of this biofilm formation is the initial 
adhesion of the bacterium to the artificial surface. Here, we used single-cell force spectroscopy (SCFS) 
to study the initial adhesion of S. aureus to central venous catheters (CVCs). SCFS performed with S. 
aureus on the surfaces of naïve CVCs produced comparable maximum adhesion forces on three types 
of CVCs in the low nN range (~ 2–7 nN). These values were drastically reduced, when CVC surfaces 
were preincubated with human blood plasma or human serum albumin, and similar reductions were 
observed when S. aureus cells were probed with freshly explanted CVCs withdrawn from patients 
without CRBSI. These findings indicate that the initial adhesion capacity of S. aureus to CVC tubing 
is markedly reduced, once the CVC is inserted into the vein, and that the risk of contamination of the 
CVC tubing by S. aureus during the insertion process might be reduced by a preconditioning of the CVC 
surface with blood plasma or serum albumin.
The gram-positive bacterium S. aureus is a common cause of medical device-related  infections1. The bacterium 
has the ability to adhere to different kinds of artificial surfaces and to form multilayered biofilms, which are 
frequently not susceptible to antibiotic  therapy2. A commonly used endovascular medical device is the central 
venous catheter (CVC), which is essential in everyday medical practice, especially in treating patients in intensive 
care  units3. However, usage of CVCs is also associated with a substantial risk of bloodstream infections (BSIs), 
and S. aureus is currently the major etiological agent of catheter-related bloodstream infections (CRBSIs)4. Sili-
cone and polyurethane (PU) are the most commonly used materials for CVC  production5, with PU displaying 
a superior permanence over silicone, however, at the cost of increased bacterial colonization  rates5. A number 
of studies were conducted in the 1980s and 1990s to elucidate the host and pathogen-related factors respon-
sible for the adhesion of S. aureus to  CVCs6–11. These studies identified cell wall-anchored/associated proteins 
as important adhesins of S. aureus to naïve  catheters9,11,12. Studies carried out with Staphylococcus epidermidis 
demonstrated that adhesion of the bacterium to the implant material is also driven by surface hydrophobicity 
and -topology13–15, and this probably also holds true for S. aureus16. Other studies demonstrated that host factors 
deposited on catheters significantly affect the binding capacity of S. aureus to the polymer  surfaces7–10,12,16. When 
inserted into the vasculature, CVC surfaces are rapidly (within seconds) covered by plasma proteins, which in 
turn alter the binding capacity of the bacterium to the implanted medical  device17. However, there is a certain 
discrepancy in the literature about the impact of plasma surface coating on the adhesion behavior of S. aureus 
to PU/CVCs. While some studies reported a positive effect of plasma on the adhesion of S. aureus to  CVCs9,18, 
others observed  no18 or even a negative effect of plasma or serum on the ability of this bacterium to adhere to 
PU-based  catheters12,16. However, based on S. aureus adhesion studies performed with untreated and explanted 
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CVCs, it can be assumed that host factors deposited on the CVC upon implantation promote rather than decrease 
binding of S. aureus to the inserted intravascular  device7,8.
In order to colonize the CVC and to form a biofilm, the bacterium first needs to get into contact with the 
medical device. This is likely to happen by different means. The bacterium might get into contact with the CVC 
while the catheter is inserted through the skin. Under these conditions, the bacterial cell residing on the skin is 
most likely getting into contact with the naïve surface of the CVC via physicochemical and capillary  forces19,20. 
It is assumed that most CRBSI originating from short-term CVCs (in place < 10 days) are of cutaneous origin, 
and gain access  extraluminally3. A second common route by which S. aureus may get into contact with the CVC 
is contamination of the fluid administered through the device. Under these conditions, native S. aureus cells are 
likely to get into contact with the luminal area of the CVC that is either undecorated (i.e. the rear tubing of the 
CVC) or decorated by plasma factors (i.e. the front tubing and the tip of the CVC). A third way of CVC coloniza-
tion by S. aureus originates from remote sources of local infection via the bloodstream (hematogenous spread). 
Under these conditions, S. aureus cells that are decorated by plasma factors are likely to get into contact with 
a CVC surface that is covered with plasma factors as well. Only little information is available yet on how these 
colonization routes affect the adhesion kinetics between S. aureus and the implanted medical device. Similarly, 
the adhesion forces between the bacterial cell and this type of implant material, and particularly the impact of 
blood plasma on the initial adhesion of S. aureus to CVC surfaces, have to our knowledge not been determined 
yet. In order to fill these gaps, we applied here a single-cell force spectroscopy (SCFS)  approach21 to determine 
the maximum adhesion forces and rupture lengths of viable, native and plasma-coated S. aureus cells to naïve 
and plasma coated PU-based CVCs.
Results and discussion
Surface characteristics of PU-based CVC tubing. Our earlier work demonstrated that the adhesion of 
staphylococci to abiotic surfaces is dominated by hydrophobic/hydrophilic interactions between bacterial cell 
wall components and the artificial  surface22,23, and that S. aureus displays stronger adhesion forces on hydropho-
bic than on hydrophilic  surfaces24. Another important factor that affects the binding capacity of S. aureus to an 
abiotic surface is surface  topology25. We and others have shown that the adhesion of S. aureus to hydrophobized 
silicon wafers and titanium decreases significantly when the roughness of the surface is increased in the low 
nanometer (nm) range (≤ 20 nm)26,27, while variations in surface topography in the higher nm to micrometer 
(µm) range (≥ 350 nm) were reported to enhance the bacterial adhesion to a  substratum28,29.
PU-based CVCs are currently the predominant catheter types used for central  lines5, however, only little 
is known about the roughness and other surface characteristics of merchandised PU-based CVCs, which may 
additionally differ substantially between manufacturers. To further elucidate these characteristics, we started our 
study with the determination of the surface topography and hydrophobicity/hydrophilicity of three CVC types 
obtained from different manufacturers that are commonly used at the Saarland University Medical Hospital 
(Fig. 1 and Table 1). All three CVC types displayed advancing water contact angles 90° < Ɵ < 130° (Table 1), indi-
cating that these surfaces are hydrophobic. Similarly, all three CVC tube surfaces exhibited a rather comparable 
overall roughness, with root mean square (RMS) roughness values between 51 and 58 nm (Table 1). However, 
the 10 µm × 10 µm height profiles recorded by AFM indicated that the three CVC types display differences in 
their surface topologies (Fig. 1). CVC surfaces of type III displayed noisy surface topologies with multiple small 
peaks and numerous bumps and valleys with height differences up to 500 nm. Type II CVC surfaces exhibited 
flatter surface topologies with a number of smaller but high bumps, and type I CVC surfaces displayed again more 
bumpy surface topologies, however, with the smallest variations between bumps and valleys (Fig. 1). When the 
skewness, the degree of asymmetry of a surface height distribution, was calculated from the AFM images, CVC 
surfaces of type II featured the highest skewness values, while CVC surfaces of types I and III displayed lower 
values that were in a comparable range (Table 1), in line with earlier findings suggesting CVC type II to exhibit 
a more irregular surface topology than CVC types I and  III15.
S. aureus displays comparable adhesion forces on different types of PU-based CVC sur-
faces. Although the quantitative and qualitative adhesion of staphylococci to CVCs has been addressed by 
many studies, the adhesion forces between S. aureus and this type of implant material have to our knowledge not 
been determined yet. Thus, we next studied the adhesion behavior of viable S. aureus cells to the CVC surfaces by 
SCFS, which allows measuring the interaction forces between a single bacterial cell and its substratum with pN 
force  resolution21. In line with our surface characterization experiments (Fig. 1 and Table 1), we detected rather 
comparable maximum adhesion forces  (Fadh) for S. aureus strain N315 on all three types of CVCs (Fig. 2a), 
which averaged between 3.1 ± 2.3 nN and 4.0 ± 2.9 nN (mean and SD). N315 cells tended to exhibit lower adhe-
sion forces on the CVC surface of type II, however, this effect was not statistically significant. A similar trend 
was observed for the rupture lengths obtained with N315 on the CVC surface of type II, which were about half 
as long as the ones observed with this strain on the CVC surface of type III (Table S1).
Since an earlier study noticed larger strain to strain variations in the capacity of S. aureus to adhere to CVC 
 surfaces16, we conducted a second series of SCFS measurements with the CRBSI-related clinical isolate HOM433 
to exclude that the findings made with N315 might be restricted to this strain. When cells of the clinical isolate 
were probed on the three naïve CVC surfaces, very similar  Fadh values and rupture lengths were observed on 
the respective CVC types (Fig. 2b and Table S1). The vast majority of the recorded retraction curves obtained 
with the two isolates displayed a clear main detachment peak with only a few discrete steps (Fig. 2c), suggesting 
the involvement of numerous bacterial adhesins and a rather abrupt detachment of the bacterial cell surface 
components from the CVC  surface23,24. The maximum adhesion forces recorded for S. aureus N315 on PU-based 
CVC surfaces in this study were in a similar range to those observed for this bacterium on silicone  rubber30, 
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and about a factor 10 higher than those found on titanium (J. Mischo, unpublished results), a commonly used 
material for orthopedic and dental  implants31. This suggests that S. aureus exhibits a comparably strong binding 
capacity to naïve PU-based CVC surfaces.
In contrast to a previous report on the adhesion of S. aureus to hydrophobized Si wafers with a very smooth 
surface topography (RMS of 0.12 nm), where the force–distance measurements with an individual bacterial cell 
provided highly superimposable retraction  curves23, we observed comparably large variations in the maximum 
adhesion forces recorded for some of the individual cells (Table S1). One reason for this might be the surface 
roughness of the CVCs tubes tested. In biophysical studies, SCFS is commonly carried out on highly defined 
and very smooth surfaces lacking larger bumps, while our test surfaces displayed numerous smaller and larger 
humps (Fig. 1). To access the impact of surface roughness on the adhesion force variation seen between repeated 
measurements with the identical bacterial probe, we additionally determined the maximum adhesion forces for 
N315 cells on FluoroDish, a hydrophobic glass  surface32 displaying a low surface roughness (RMS = 1.1 ± 0.2 nm) 
Figure 1.  AFM height images of the surfaces of CVC types I to III. 10 × 10 µm areas of the CVC tubes were 
scanned by AFM as outlined in “Materials and methods” section. (a) Representative 2D AFM height images of 
the CVC types I to III. (b) Overlay of height profiles along the lines indicated in (a). (c) Representative 3D AFM 
height images of the same regions as displayed in (a).
Table 1.  Surface characteristics of the tubing of CVC types I–III. Data are represented as mean ± SD.
CVC type
I II III
Advancing water contact angle Ɵ (°) 119 ± 6 109 ± 1 109 ± 1
Root-mean-square roughness (nm) 57.5 ± 6.9 50.8 ± 7.1 58.3 ± 18.3
Skewness 0.64 ± 0.77 1.69 ± 0.67 0.44.3 ± 0.1
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Figure 2.  Adhesion kinetics of S. aureus on naïve CVC types I to III. Individual exponential growth phase cells 
of S. aureus were immobilized on cantilevers and used for SCSF on naïve surfaces of CVC types I to III. (a,b) 
Maximum adhesion forces extracted from the retraction curves recorded by SCFS with cells of strains N315 (a) 
and HOM433 (b) on the naïve surfaces of CVC types I to III. Data are presented as box and whisker plots (min-
to-max) of 50 values obtained with 5 individual cells per strain. ns, not significant (Kruskal–Wallis test followed 
by Dunn’s post hoc test). (c) Representative retraction curves collected from cells that were probed with naïve 
CVC surfaces from manufacturers I to III. (d) Overlays of 10 retraction curves obtained with a single N315 cell 
on glass and the surface of CVC type II, respectively. (e) Maximum adhesion forces of cells of strain N315 on the 
surface of CVC type III. Data are presented as box and whisker plots showing the interquartile range (25–75%; 
box), median (horizontal line), and whiskers (bars; min/max) of 10 values obtained per individual cell. *P < 0.05; 
**P < 0.01 (Kruskal–Wallis test followed by Dunn’s post hoc test).
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and lacking any major humps. On this type of glass surface, N315 produced retraction curves and adhesion 
forces that were highly similar (Fig. 2d), suggesting that surface roughness might indeed be a factor contribut-
ing to the large variation in adhesion forces seen for individual S. aureus cells on the CVC surfaces in repeated 
measurements. Another explanation for this phenomenon might be chemical and biomechanical variations in 
surface composition. PU-based materials are formed in block copolymers creating a two phase microstructure 
composed of 10–100 nm microdomains with different physicochemical  properties33. It has been shown that these 
microdomains display differences in the adsorption of plasma proteins and cell  attachment34.
Similar to the variations in adhesion forces seen for repeated measurements with the same bacterial probe, 
we also noticed in part significant variations in the mean adhesion forces between individual cells (Fig. 2e and 
Table S1). This observation is rather common for SCFS studies with  staphylococci22,24,26,31,35 and probably due 
to cell-to-cell variations that occur even between individual cells sampled from the same cell culture and at the 
same time point.
Precoating of the CVC surface with human blood plasma decreased the adhesion force of S. 
aureus to CVC surfaces. When inserted into the body, blood-exposed implanted materials are decorated 
within seconds by blood plasma  factors36, but it is a matter of debate whether this positively or negatively affects 
the adhesion capacity of S. aureus to the implanted medical  device9,16,18,37. Additionally, the impact of blood 
plasma on the initial adhesion of S. aureus to CVC surfaces has not been determined yet. In order to address 
this issue, we performed SCFS with S. aureus N315 on CVC fragments that were preincubated for 30 min with 
human blood plasma (HBP). Since PU-based materials are known to alter their surface properties in aqueous 
 solutions34, we first determined the maximum adhesion forces for N315 on the surfaces of CVC tubes that were 
precultured for 30 min in PBS. Although no clear signs of swelling were observed for this comparably short time 
period, we noticed significant differences in the  Fadh values on PBS preincubated CVC surfaces when compared 
to naïve CVC surfaces (Fig. 3A). This suggests that the contact with aqueous solutions for 30 min already alters 
the surface properties of PU-based CVCs in a way that promotes (CVC types I and II) or decreases (CVC type 
III) S. aureus adhesion.
When force–distance curves of strain N315 were recorded on catheter surfaces that were preincubated for 
30 min with HBP, significant decreases in  Fadh values were observed for all three CVC types (Fig. 3B), which 
dropped by ≥ tenfold when compared to the  Fadh values obtained on the PBS preincubated CVC surfaces of the 
same type. To substantiate this observation, we carried out a second set of experiments with strain HOM433 on 
surfaces of CVC type III (Fig. 3C), which yielded a very similar result. These findings strongly suggest that the 
adhesion capacity of S. aureus to this type of medical device is drastically reduced, once the CVC is inserted into 
the vein, and support earlier work reporting a negative effect of plasma or serum on the adhesion of S. aureus 
to polymer  materials12,16.
One factor that might explain the lower  Fadh values observed for S. aureus on HBP-precoated CVC surfaces is 
surface hydrophobicity, as S. aureus displays a reduced adhesion capacity to hydrophilic  surfaces24. Thus, we next 
determined the impact of a HBP preconditioning on the wettability of the CVC tubing. HBP-pretreated surfaces 
of CVC types I, II and III displayed advancing water contact angles of 55 ± 4°, 39 ± 4° and 51 ± 5°, respectively. 
These findings suggest that a HBP preconditioning renders the surface of the CVC tubing from hydrophobic 
to hydrophilic, and that this change in wettability might indeed contribute to the reduced maximum adhesion 
forces observed for S. aureus on the HBP-precoated CVC tubing. Specific receptor–ligand interactions between 
bacterial cell wall proteins and blood plasma factors deposited on the CVC tubing, on the other hand, seem to 
be of minor importance, albeit of the fact that S. aureus expresses a number cell wall-anchored or -associated 
adhesins capable of binding to blood plasma factors such as fibrinogen (Fg), fibronectin, immunoglobulin G, 
vitronectin, and von Willebrand factor (vWF),  respectively38, which all were reported to adsorb onto the surfaces 
of implant materials upon contact of the foreign material with  blood39,40.
S. aureus displayed low adhesion forces on explanted CVC tubings. Flow conditions and dwell-
ing times are both known to affect the composition of the plasma factor coating on implanted  materials36 and 
to induce conformational changes of the adsorbed  proteins34. To see if and how our findings received with the 
in vitro HBP preincubated CVC surfaces can be matched with the in vivo situation, we next tested the adhesion 
forces of strains N315 and HOM433 on freshly explanted CVC tubing withdrawn from patients that did not 
suffer from CRBSI. When force–distance curves were recorded on this type of material, we observed maximum 
adhesion forces (Fig. 3D) that were very similar to the  Fadh values determined with N315 and HOM433 on the 
in vitro HBP preincubated CVC surfaces (Fig. 3B,C), suggesting that our findings received with the in vitro test 
system can be correlated with the in vivo situation.
Coating of the S. aureus cell wall with HBP factors further reduced the adhesion force of the 
bacterial cell to the HBP-precoated CVC surface. A third route of CVC colonization by S. aureus 
originates from hematogenous spreading of the bacterium from other infection  foci41. Under these conditions, S. 
aureus cells that are decorated by plasma factors and/or attached to blood cells get into contact with a CVC sur-
face that is covered with plasma factors and blood cells as well. In order to mimic this scenario, we preincubated 
N315 cells for 30 min with HBP before we recorded the force–distance curves with such cells on HBP-precoated 
CVC fragments of type III (Fig. 3E). The preconditioning of the bacterial cell with HBP further reduced the 
maximum adhesion force between N315 and the HBP-precoated CVC surface, when compared to the adhesion 
forces observed for uncoated N315 cells on HBP preincubated CVC surfaces. These findings suggest that blood 
borne S. aureus cells exhibit a rather lower adhesion capacity to CVC surfaces inserted into the vasculature, at 
least under static conditions. However, our experimental setup lacks at least two major factors relevant for the 
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adhesion of S. aureus to implant material that is inserted into the vasculature, which are the presence of blood 
cells, e.g. platelets bound to the catheter surface that might be exploited by the bacterium for adhesion, and shear 
flow. S. aureus cells are reported to adhere to platelets with high  efficiency42, and platelets adhere to implanted 
material inserted into the  bloodstream43. Although it is unknown yet to which extent S. aureus adheres to blood-
exposed implant material via platelets, it can be assumed that platelets contribute to the adhesion and biofilm 
formation of S. aureus to/on CVCs, given the interplay between S. aureus and this type of blood  cells42. Another 
factor that is likely to be important for the binding capacity of S. aureus to implant material that is inserted into 
the vasculature is shear flow. Most regions of the CVC tubing that are inserted into larger veins are exposed to 
high shear  stress44, and we and others have shown that binding of S. aureus to activated endothelium under 
high shear flow is mediated predominantly via elongated vWF  fibers45,46. vWF unfolding is only observed when 
vWF is tethered to a surface and exposed to high shear  stress47. vWF is also known to adsorb on blood-exposed 
 catheters40. Although vWF seems to be of minor importance for platelet adhesion on blood-exposed implant 
 material48, its elongated form is likely to contribute to the adhesion capacity of S. aureus to the blood-exposed 
implant material under high shear flow. To access such shear flow-induced phenomena, the actual flow profile 
must be precisely determined (e.g. in a microfluidic setup with particle imaging velocimetry), which is beyond 
the scope of the present study.
Figure 3.  Adhesion kinetics of S. aureus on precoated CVC surfaces. Individual exponential growth phase cells 
of S. aureus strains N315 and HOM433 were used for SCSF on naïve and pretreated CVC surfaces. (A) Impact 
of a PBS preincubation (30 min) on the maximum adhesion forces of N315 cells on the surfaces of CVC types I 
to III. (B) Impact of a HBP preconditioning (30 min) on the maximum adhesion forces of N315 on the surfaces 
of CVC types I–III. (C) Impact of a HBP pretreatment (30 min) on the maximum adhesion forces of HOM433 
on the surface of CVC type III. (D) Maximum adhesion forces of untreated N315 or HOM433 cells on the 
surface of freshly explanted CVCs of types I and II obtained from patients without CRBSI. (E) Impact of a HBP 
preconditioning of N315 cells on the maximum adhesion force of the bacterium formed on HBP-precoated 
surfaces of CVC type III. Data are presented as box and whisker plots (min-to-max) of 40–60 values obtained 
with 4–6 individual cells per condition. The detection limit of our system is indicated by horizontal dashed lines. 
*P < 0.05; **P < 0.01 (Mann Whitney U test).
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The adhesion force of S. aureus to CVC surfaces is reduced by a preincubation of the CVC tub-
ing with serum albumin or Fg. Serum albumin and Fg are the main proteinaceous plasma factors that are 
adsorbed on blood-exposed polymer  surfaces49, and the preincubation of a CVC with serum albumin has been 
shown to reduce the adhesion of S. aureus to the CVC  surface8. In line with the latter publication, we also found 
a strong decrease in the maximum adhesion forces between S. aureus N315 and the catheter surface of type II 
when the catheter fragment was preincubated with human serum albumin (HSA; Fig. 4a). The adhesion forces of 
N315 on the CVC surface dropped by a factor of about 35 when the catheter fragments were preincubated with 
40 mg/ml of HSA, a common albumin concentration found in human  blood50. Notably, similar reductions in the 
mean  Fadh values were observed even when HSA concentrations as low as 0.4 mg/ml were used for preincubation 
(Fig. 4a), suggesting that much lower concentrations of this blood plasma protein than the ones usually found 
in human blood are sufficient to markedly suppress the initial adhesion capacity of S. aureus N315 to PU-based 
CVC surfaces.
A smaller, but still highly significant reduction in mean  Fadh values was also observed when N315 cells were 
probed with CVC fragments of type II that were preincubated with physiological concentrations of human Fg 
(Fig. 4b). The latter observation is surprising since earlier work reported positive effects of Fg on the adhesion 
capacity of S. aureus to implanted materials in quantitative adhesion  assays7,51. Given these differences in the 
impact of Fg on the qualitative and quantitative adhesion of S. aureus to implanted material in vitro, we hypoth-
esize that a decoration of the CVC surface with physiological concentrations of Fg reduce the interaction force 
between S. aureus and the implanted material, while the quantitative adhesion capacity of S. aureus to this type 
of implanted material is promoted by the presence of this host factor on the CVC surface. This scenario might 
also hold true for human blood plasma factors adsorbed on the CVC surface, which were found here to strongly 
decrease the adhesion forces between S. aureus and PU-based CVCs, while others observed enhanced numbers 
of S. aureus cells on different types of catheter surfaces that were withdrawn from  patients8. However, in the 
latter study, the quantitative adhesion of S. aureus to explanted catheter fragments was compared to catheter 
fragments that were precoated with serum albumin, leaving the question open to which extent S. aureus would 
have adhered to the respective naïve catheter fragments.
Concluding remarks. To our knowledge, this is the first time that SCFS with S. aureus was done on authen-
tic, commercially available CVC material to determine the adhesion forces between a commonly used implanted 
medical device and this major nosocomial pathogen. We showed that S. aureus binds with high affinity to PU-
based CVC tubing and that this adhesion can be markedly reduced by a pretreatment of the CVC tubing with 
blood plasma or serum albumin. The preconditioning of the CVC surface with serum albumin, a procedure 
suggested to reduce the risk of thrombus formation on blood exposed medical  devices52, might also be a valid 
tool to decrease the risk of contamination of the CVC tubing with S. aureus, particularly during the insertion 
Figure 4.  Impact of HBP-factors on the adhesion of S. aureus to CVC tubing. Individual exponential growth 
phase cells of S. aureus strain N315 were used for SCSF on naïve and pretreated tubing of CVC type II. (a) 
Impact of human serum albumin (HSA) on the maximum adhesion forces of untreated N315 cells formed 
on HSA (0.4, 4, and 40 mg/ml for 30 min) pretreated CVC surfaces. (b) Impact of human fibrinogen (Fg) on 
the maximum adhesion forces of untreated N315 cells formed on Fg (0.4 mg/ml for 30 min) precoated CVC 
surfaces. Data are presented as box and whisker plots (min-to-max) of 60 values obtained with 6 individual cells 
per condition. The detection limit of our system is indicated by dashed lines. **P < 0.01 (Kruskal–Wallis test 
followed by Dunn’s post hoc test [a] or Mann Whitney U test [b]).
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process. The reduced adherence strength of S. aureus cells to blood plasma precoated PU-based CVC tubing is 
probably due to a decrease in surface hydrophobicity of the implant material evoked by the adsorbed plasma fac-
tors. This assumption is in line with earlier findings made with S. aureus and different types of venous catheters 
demonstrating that chemical modifications which rendered the catheters more hydrophilic also decreased the 
quantitative adhesion of the bacterium to the modified  surfaces18,53,54, and supports the idea that increasing the 
hydrophilicity of PU-based CVC tubing might be a valuable tool to lower the risk of bacterial colonization of 
this implanted medical  device6. Our data suggest furthermore that a chemical modification of the tubing surface 
might not be needed to achieve this goal.
Materials and methods
Bacteria and bacterial probes. S. aureus strain N315 was obtained from the Network on Antimicro-
bial Resistance in S. aureus (NARSA) strain collection (Catalog Number: NRS70). The clinical S. aureus isolate 
HOM433 was collected from a CVC that was removed from a patient suffering from a catheter-related S. aureus 
blood stream infection at the Saarland University Hospital, Homburg, Germany. The bacteria were grown on 
Tryptic Soy Agar Plates with 5% sheep blood (Becton Dickinson [BD], Heidelberg, Germany), and subsequently 
multiplied in Tryptic Soy Broth (TSB, BD) in Erlenmeyer flasks using a culture to flask volume of 1:10 for 16 h 
at 37 °C and 150 rpm. On the next day, the bacterial cell number was set to an optical density at 600 nm of 0.05 
in TSB and bacterial cells were grown for 2.5 h at 225 rpm to the exponential growth phase. After harvesting, 
bacterial cells were centrifuged for 1 min at 12,000 rpm and were washed twice with phosphate buffered saline 
(PBS, pH 7.4) to remove debris and extracellular material. Bacteria were then prepared for AFM and diluted 1:50 
in PBS, where bacterial aggregates were separated with an ultrasonic probe (B. Braun, Melsungen, Germany) for 
15 s at 50 W. Next, a single bacterium was attached to a polydopamine-coated tipless AFM cantilever (MLCT-0 
with a nominal spring constant of 0.03 N m−1 from Bruker-Nano, Santa Barbara, USA) via a micromanipulator 
(Narishige Group, Tokyo, Japan) as described  in21. The functionalization of the cantilever was controlled opti-
cally with an inverted microscope and by force–distance measurement on a glass-bottomed petri dish (FluoroD-
ish FD35-100; World Precision Instruments, Friedberg, Germany). The viability of the bacterial cell at the end of 
the force/distance measurements was confirmed by live/dead staining using the LIVE/DEAD BacLight Bacterial 
Viability Kit (Thermo Fisher Scientific, Dreieich, Germany).
Human samples. Human blood was obtained from healthy volunteers older than 18 years of age. Informed 
written consent was obtained from all participants. Explanted CVCs were obtained from the Department of 
Internal Medicine V, Pneumology and Intensive Care Medicine, Saarland University, Homburg, Germany. The 
study design was approved by the Ethics Committee of the Medical Association of Saarland (code numbers 
95/18 and 39/20) before recruitment and study initiation. The study was performed according to the guidelines 
of the Declaration of Helsinki. The acquisition procedures of blood and explanted CVC samples, respectively, 
were checked and approved by the local ethics committee.
Substrate preparation. CVC tubing samples were prepared from the Arrow CVC set DE-14703-S (Tel-
eflex Medical GmbH, Fellbach [type I]), B. Braun Certofix Trio S 720 (B. Braun, Melsungen, Germany [type 
II]), and Vygon Seldipur Safe (Vygon, Aachen, Germany [type III]). Catheter packages were opened and CVCs 
handled in a level 2 biosafety cabinet to reduce contaminant deposition on the catheter surface. The CVC tubing 
was cut with a sharp scalpel into ~ 0.5 cm fragments, and single fragments were attached to a flat glass-bottom 
petri dish with a water-resistant glue (Pattex, Düsseldorf, Germany), which was allowed to harden for 30 min 
under the BSC to strengthen the fixation between catheter and glass surface. For the fixation of explanted CVC 
fragments, sample fixation was done the same way, but the glass petri dish was additionally placed in a humidity 
chamber to prevent the biological coating on the CVC from drying. HBP was derived from freshly withdrawn 
blood collected in S-Monovette lithium-heparin blood collection tubes (Sarstedt, Nümbrecht, Germany) that 
was centrifuged at 5000 rpm for 2 min. HBP was transferred to a fresh reaction tube, centrifuged one more time 
under the same conditions to remove any cell material, and then stored in a fresh reaction tube at − 80 °C until 
usage.
Surface characterization of the CVC tubing. For mapping of the height topography of the CVC tubing, 
fragments of the three CVC types were scanned in PBS in Peak Force Tapping intermittent contact mode with an 
atomic force microscope (Bioscope Catalyst; Bruker Nano). For measurements in PBS, silicon nitride tips (SNL-
10 with nominal spring constant of 0.35 N/m from Bruker-Nano) were used. Typically, an area of 10 µm × 10 µm 
(256 × 256 pixels) was scanned with a scan rate set to 0.1 Hz. The resulting images were flattened (second order) 
and plane fitted (first order), and used to determine roughness parameters with the Nanoscope Analysis software 
1.9 (Bruker Nano). Water contact angle determinations on CVC surfaces were done as follows: From each CVC 
type, 2 cm long pieces were cut off and mounted on a straight needle. Pieces were immersed into ultrapure water 
at a constant velocity of 1 mm/s using an automated setup. At the same time, the water surface around the CVC 
pieces was recorded with a camera from the direction perpendicular to the line of movement at frame rates of 
10 frames per second. Afterwards, the CVC pieces were placed in HBP for 30 min at 37 °C, subsequently rinsed 
8-times with water, and the wettability of the precoated surfaces recorded as described above. The water contact 
angles before and after plasma coating were determined from every frame of the recorded movies using a self-
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Single-cell force spectroscopy. CVC fragments were attached to flat-bottom glass petri dishes as out-
lined above, covered with PBS, and measurements were started within five min to mimic the adhesion of single 
bacterial cells to the naïve surface. The bacterial probe was placed above the center of the catheter, and carefully 
approached towards the surface. 10 force–distance curves were recorded per bacterial probe on the crest of each 
CVC fragment with a force trigger set to 300 pN, a lateral distance between two force–distance curves set to 
1 µm, the ramp velocity adjusted to 160 nm/s and a ramp size of 800 nm. For the preconditioning of the CVC 
tubing with HBP (derived from whole blood withdrawn from at least three healthy volunteers), HSA (purchased 
from Merck Millipore, Darmstadt, Germany), or human Fg (purchased from Sigma-Aldrich, Steinheim, Ger-
many), fixed CVC pieces were covered with a droplet of HBP, HSA (0.4, 4, and 40 mg/ml), or Fg (0.4 mg/ml), 
respectively, incubated for 30 min at 37 °C, and subsequently washed eight times with PBS to remove loosely 
attached plasma factors/proteins that might distort the AFM measurements. Precoated CVC fragments were 
again covered in PBS, and force–distance curves recorded as outlined above. Analysis and depiction of force–
distance curves were done with the Nanoscope Analysis software and OriginPro 2019b (OriginLab Corporation, 
Northampton, MA, USA).
Statistical analyses. The statistical significance of changes between groups was assessed with Kruskal–
Wallis tests followed by Dunn’s post-hoc tests (3 and more groups) or the Mann–Whitney U test (two groups) 
using the GraphPad software package Prism 6.01. p values < 0.05 were considered statistically significant.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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